Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Complex multimorbidity in hemodialysis patients: Study in a metropolitan region in Brazil

  • Ana Cristina de Oliveira Soares ,

    Contributed equally to this work with: Ana Cristina de Oliveira Soares, Glenda Blaser Petarli, Monica Cattafesta

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

    Affiliation Graduate Program in Collective Health, Federal University of Espírito Santo, Vitória, ES, Brazil

  • Glenda Blaser Petarli ,

    Contributed equally to this work with: Ana Cristina de Oliveira Soares, Glenda Blaser Petarli, Monica Cattafesta

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

    Affiliation Graduate Program in Collective Health, Federal University of Espírito Santo, Vitória, ES, Brazil

  • Monica Cattafesta ,

    Contributed equally to this work with: Ana Cristina de Oliveira Soares, Glenda Blaser Petarli, Monica Cattafesta

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

    Affiliation Graduate Program in Collective Health, Federal University of Espírito Santo, Vitória, ES, Brazil

  • Edson Theodoro dos Santos Neto ,

    Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

    ‡ ETSN and LBS also contributed equally to this work.

    Affiliation Graduate Program in Collective Health, Federal University of Espírito Santo, Vitória, ES, Brazil

  • Luciane Bresciani Salaroli

    Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

    lucianebresciani@gmail.com

    ‡ ETSN and LBS also contributed equally to this work.

    Affiliation Graduate Program in Collective Health, Federal University of Espírito Santo, Vitória, ES, Brazil

Abstract

The objective of this article was to analyze the factors associated with complex multimorbidity (CMM) among hemodialysis patients in a metropolitan region in southeastern Brazil. To this end, a cross-sectional epidemiological survey was carried out with 1,024 individuals in the year 2019. CMM data were collected through the application of a questionnaire to hemodialysis patients. The binary logistic regression model was used to estimate odds ratios (OR) and 95% confidence intervals (95%CI) between independent variables and CMM. The prevalence of CMM was 81% and the results indicated that: living in cities with a low rate of general mortality (OR = 0.395, 95%CI = 0.179–0.870), being aged between 18 and 29 (OR = 0.402, 95%CI = 0.196–0.825), having an elementary education (OR = 0.536, 95%CI = 0.290–0.966) and assessing health as good/very good (OR = 0.446, 95%CI = 0.301–0.661) are factors that reduced the chances of having CMM, whereas a longer period of hemodialysis (OR = 1.779 and 95%CI = 1.057–2.997) increased the chances of CMM. The findings show that characteristics of the social and individual context are associated with CMM in hemodialysis patients, signaling the need for public health policies that include monitoring the complex multimorbidity condition among individuals undergoing hemodialysis treatment.

Introduction

The term “multimorbidity” emerged in Europe in the final half of the twentieth century [1] and, according to the World Health Organization (WHO) [2], refers to the simultaneous occurrence of two or more chronic conditions/diseases in the same individual. Interest in the study of multimorbidity has grown, especially as a result of data that show the increase both in life expectancy and in the prevalence and incidence of chronic noncommunicable diseases (NCDs) among populations [3].

Although the definition of multimorbidity proposed by the WHO is the one most widely adopted [4], there is still no consensus on this concept [5], including regarding a classification standard [6]. However, the point of convergence among authors who study the subject is the association of multimorbidity with a higher mortality rate, polypharmacy and increased use of health services, which represents an even greater challenge for health systems, especially public ones [7].

Despite the negative impacts on health, studies on multimorbidity are recent and classification methods are not very standardized, which limits the comparison of results [6]. Another limiting factor is the use of this concept in a population that is already potentially multimorbid, such as individuals in hemodialysis treatment, since they routinely present associated chronic comorbidities [8].

Although studies on multimorbidity in individuals undergoing hemodialysis are scarce, understanding this condition in this group is useful, especially in providing data to guide the therapeutic approach, allocation of resources and monitoring of individuals within the health network [9, 10].

Thus, an alternative for studying of this condition in individuals with more than two chronic conditions would be the evaluating of the occurrence of complex multimorbidity—defined by Harrison et al. [11] as the existence of three or more chronic conditions that affect three or more different organic domains (body systems)—which assesses the impairment of body systems, rather than assessing of multimorbidity simply by counting diseases, and is applicable to those individuals undergoing hemodialysis treatment.

Thus, based on the above, this study presents an innovative proposal in the analysis of complex multimorbidity in individuals undergoing hemodialysis treatment in a metropolitan region in southeastern Brazil.

Materials and methods

This is a cross-sectional study that considered the total number of users who underwent hemodialysis in the Região Metropolitana da Grande Vitória, Espírito Santo, Brazil (RMGV-ES), from February to September 2019. The RMGV-ES aggregates the largest number of individuals undergoing hemodialysis procedures in the state of Espírito Santo.

The inclusion criteria were being 18 years of age or older, undergoing hemodialysis treatment (weekly frequency of three sessions or more lasting over two hours per session) in the RMGV-ES, walking independently without the need for assistance and having a confirmed diagnosis on the chronic kidney disease chart by the International Classification of Diseases, version 10 (ICD-10): N18 (chronic renal failure), N180 (end-stage renal disease), N188 (other chronic renal failure), N189 (unspecified chronic renal failure) and N19 (unspecified renal failure).

Chronic kidney disease was chosen as the initial criterion for analysis of other morbidities in all patients in hemodialysis treatment.

The exclusion criteria were: being hospitalized, having impaired speech and/or hearing, having physical difficulties that prevented data collection and having been transferred to receive hemodialysis in clinics located outside the RMGV-ES.

Out of the total number of individuals in the target population (1,351), 304 were excluded due to the established criteria and thus 1,047 individuals were eligible for the research. Of these, 23 (2.2%) refused to participate in the survey. Thus, the final population for the study comprised 1,024 individuals. It should be emphasized that, as this was an epidemiological census study involving the entire population undergoing hemodialysis during the study period, no sample size calculation was performed.

The data (S1 File) were collected during hemodialysis sessions via the application of a semi-structured questionnaire by interviewers trained for this purpose. The data collection instrument was prepared with validated questionnaires.

Complex multimorbidity (CMM) was characterized by the occurrence of three or more chronic conditions/diseases that affect three or more domains or different body systems [11], excluding chronic kidney disease, since having this disease was an inclusion criterion in the study.

To identify the domains/organic systems related to each condition/disease, the ICD-11 (WHO) was used with the following classification: endocrine, nutritional or metabolic diseases (dyslipidemia, diabetes, thyroid disorders); circulatory system (cardiac arrhythmia, arterial hypertension, heart attack, stroke); mental, behavioral or neurodevelopmental disorders (depression, Alzheimer’s disease); neoplasms (cancer); genitourinary system (kidney diseases—which are classified in this group, but were not included, as this was a criterion for inclusion in the study—and infertility); digestive system (liver cirrhosis); nervous system (Parkinson’s disease); pulmonary system (asthma, bronchitis, pulmonary emphysema); musculoskeletal system or connective tissue (repetitive strain injuries, work-related musculoskeletal disorders, osteoarthritis, herniated disc).

Data on the occurrence of chronic conditions/diseases were collected by the question “Has a doctor or other health professional ever told you that you had any of these diseases?”. The nontransmissible diseases/conditions investigated in this research were: arrhythmia, infarction, stroke, diabetes mellitus, disc herniation, arthrosis, Parkinson’s disease, Alzheimer’s disease, liver cirrhosis, infertility, cancer, thyroid disorders, asthma, bronchitis, pulmonary emphysema, arterial hypertension, dyslipidemia and depression. In the few cases where it was not possible to obtain information about nontransmissible diseases through self-reporting (e.g., patient did not know the answer), the medical records were consulted. In this case, the collection of patient data from medical records was carried out on the same day that the patient responded to the questionnaire.

The analysis model is presented in Fig 1, with the independent variables organized in blocks. The social context variables corresponded to the indicators of the patients’ municipalities of residence. The data were obtained from the Brazilian Institute of Geography and Statistics (IBGE) [12, 13] and were defined as: Municipal Human Development Index (IDHM), Coverage of the Family Health Strategy (ESF), Primary Health Care Coverage (APS) and General Mortality Index. The Municipal Human Development Index (IDHM) is an index adapted to the reality of Brazilian municipalities that summarizes social indicators referring to three dimensions related to human development: longevity, income and education. The IDHM was classificated in “very high” (above 0.800); “high” (between 0.700 and 0.800); “medium” (between 0.550 and 0.700) and “low” (below 0.550). It is noteworthy that in the RMGV, there are no municipalities classified with low IDHM. The variable “Coverage of the Family Health Strategy” (ESF) corresponds to the percentage of the municipality’s population covered by the Family Health Strategy (ESF). It was classified in (“high” defined as surpassing 75% of the population, “medium” defined as ranging between 50% and 75% of the population, and low defined as below 50% of the population). The Family Health Strategy (ESF) is a Brazilian public policy that aims to increase the effectiveness of public health services for the population. It is based on a Primary Care model of care, organized through the work of multidisciplinary teams in an assigned territory, which develops health actions based on knowledge of the local reality and the needs of its population. The variable”Primary Health Care Coverage” (APS) corresponds to the estimated population coverage of Primary Care teams in each municipality and was also categorized into “high” defined as surpassing 75% of the population, “medium” defined as ranging between 50% and 75% of the population, and “low” defined as below 50% of the population. The variable “General Mortality Index” corresponded to the Mortality Index of the municipality where the hemodialysis patient lived. The data were obtained from the Information Technology Department of the Unified Health System and classified as “> 10/1,000 inhabitants”, “5.1–10/1,000 inhabitants” and “≤ 5/1,000 inhabitants” [14].

thumbnail
Fig 1. Analysis model.

IDHM, Municipal Human Development Index; ESF, Family Health Strategy coverage (the gateway to public health policy in Brazil); APS, Primary Health Care (Public health policy in Brazil); HD, Hemodialysis.

https://doi.org/10.1371/journal.pone.0303068.g001

The group of individual characteristics included personal, social and health needs variables. As personal variables, we considered: age group, gender, self-reported race/color, time on hemodialysis, previous conservative treatment (based on medication and dietary modifications, such as protein restriction), and duration of chronic kidney disease. As social variables, it was considered: income, education (primary education refers to less than 8 years of schooling, elementary education encompasses 8 to 11 years of schooling, and secondary and tertiary education encompasses 11 or more years of schooling), work activity, total social capital (these were classified according to Reisen et al. [15] into “high”, “moderate” and “low social capital”, based on the indicators proposed by Grootaert (2001) [16]. The self-assessment variable of health status was categorized into “good,” “very good”, “poor” and “very poor” and corresponded to the variable related to health needs.

In the group of variables related to “income indicators”, were include the variables: regular frequency of hemodialysis, regular practice of physical activity and variables related to health habits (practice of physical activity, alcohol consumption and smoking history, based on the CAGE questionnaire, and access to health services, classified as high, moderate and low, according to Oliveira Soares et al. [17].

To evaluate the reproducibility of the data collection instrument, a pilot test was carried out between October and December 2018 with 57 individuals undergoing hemodialysis treatment in a municipality outside the metropolitan region studied. The sample for the pilot test comprised all individuals undergoing dialysis treatment at a hemodialysis clinic located outside the geographic region of the study. These individuals were not considered for the purposes of the article’s analyses. The pilot test was divided into two parts—test and retest—with a difference of 15 days between them and with the questionnaire being applied to the same patients in both. The test and retest analyses were performed using the Kappa coefficient and McNemar’s test. WinPepi software (PEPI-for-Windows version 11.65, Hebrew University, Jerusalem, Israel) was used, and the confidence interval adopted was 95% with p < 0.05. The results of the adjusted Kappa were above 0.6, showing a high level of agreement. In the McNemar test, values of p > 0.05 were obtained, demonstrating high agreement and low disagreement, and indicating its good reproducibility.

The analysis of the research results was performed using the IBM SPSS® Statistics for Windows software, version 22.0 (Armonk, NY: IBM Corp), based on bivariate association statistics between the outcome, complex multimorbidity, and the independent variables through the Chi-square test and/or Fisher’s exact test. Model quality was assessed using the Hosmer–Lemeshow test. Missing data were disregarded from the analyzes due to low data loss. When such a situation occurred, the difference in the number of individuals in their respective variable in the tables was indicated.

Binary logistic regression analysis was performed to estimate the associations of the independent variables with the outcome—complex multimorbidity (characterized by the presence of three or more nontransmissible diseases, except for chronic kidney disease, which was the key inclusion criterion in the study), affecting three or more different organic systems. A regression model was developed using variables that exhibited a statistical significance level of α < 0.05 in the bivariate analysis results. The introduction of variables into the regression model was conducted hierarchically, in blocks. Given the hierarchical nature of the analysis, the final model accounted for the adjustment of all variables integrated into the model, specifically: Block 1 comprised income indicators; Block 2 included income indicators and individual characteristics; and Block 3 encompassed income indicators, individual characteristics, and aspects of the social context. The categories that increased the risk of developing complex multimorbidity were considered as the reference for logistic regression analysis. The stepwise variable selection method with the likelihood ratio test was used, adopting the model with the highest fit according to the Hosmer–Lemeshow test (p > 0.05, closer to 1), multicollinearity (tolerance > 0.1 and variance inflation factor < 10), minimum sample size for the number of model variables (> 20 individuals per variables in the model and > 5 cases in each category of variables) and absence of outliers (absence of standardized residuals > + 3 standard deviations, up to 1% of standardized residuals between + 2.5 and 3 standard deviations and up to 5% of standardized residuals between 2.0 and 2.5 standard deviations and/or Cook’s distance < 1 and DFBeta < 1). In the final model, only the variables that presented a significance level of α < 0.05 were maintained. It should be noted that only hemodialysis patients with responses in all variables were included in this analysis.

The research was approved by the Research Ethics Committee of the Health Sciences Center of the Federal University of Espírito Santo, under opinion number 4.023.221 and CAAE number 68528817.4.0000.5060. All hemodialysis units formally authorized the research through a letter of consent, as did all the research participants, who only started participating after reading and signing the written Informed Consent Form.

Results

The prevalence of complex multimorbidity among patients undergoing hemodialysis treatment was 81.1% (915 individuals). The average age of those surveyed was 54.7+0.59 years old, with the predominant age group being 30 and 59 years old (n = 528, 51.6%). Most individuals (57.9%) lived in municipalities with a high IDHM, while only 388 (37.9%) lived in cities with a mortality rate of up to five deaths per 1,000 inhabitants. Most individuals were male (n = 581, 56.7%), self-declared black or brown (n = 737, 72%), with high APS coverage (n = 477, 46.6%) and a low coverage of ESF (n = 47, 46.2%).

With regard to chronic kidney disease, 525 (51.3%) had the disease for less than five years and 679 individuals (66.6%) had not undergone previous conservative treatment. As regards to hemodialysis, 368 individuals (35.9%) had been undergoing the procedure for less than three years and most individuals self-assessed their health status as good/very good (n = 633, 61.8%) (Table 1).

thumbnail
Table 1. Descriptive analysis of the variables of exposure to complex multimorbidity of hemodialysis patients, Brazil, 2019.

https://doi.org/10.1371/journal.pone.0303068.t001

In terms of the income range, 555 (56.2%) of the hemodialysis patients had a monthly income of less than or equal to two minimum wages in force (minimum wage in force at the time of the study: R$998.00, equivalent to US$189.54). Most respondents were retired or no longer undertaking work activities and were receiving social benefits (n = 547, 54.2%), while only 209 (25.2%) enjoyed the highest level of access to health services.

In regard to total social capital, just 254 (24.9%) were categorized as having high total social capital. As for behavioral habits, only 95 (9.3%) consumed alcohol regularly, 53 (5.2%) were smokers and the vast majority (n = 794, 77.6%) did not practice physical activity (Table 1).

The results of the bivariate analyses showed that the variables IDHM (p = 0.007), General Mortality Index of the municipality of residence (p = 0.003), age group (p<0.001), sex (p = 0.037), hemodialysis duration (p = 0.013), previous conservative treatment (p = 0.043), education (p = 0.048), work activity (p = 0.047), self-assessment of health status (p<0.001) and regular practice of physical activity (p = 0.047) were related to CMM (Table 2).

thumbnail
Table 2. Presence of complex multimorbidity according to social context, individual characteristics and income indicators of hemodialysis patients, Brazil,2019.

https://doi.org/10.1371/journal.pone.0303068.t002

However, after performing binary logistic regression, the following remained in the final model and reduced the chances of CMM were: residing in a municipality with a General Mortality Index of up to five deaths per group of 1,000 inhabitants (p = 0.021; OR = 0.395; 95%CI = 0.179–0.870); belonging to the age group between of 18 and 29 years old (p = 0.013; OR = 0.402; 95%CI = 0.196–0.825); having an elementary education (p = 0.038; OR = 0.536; CI95% = 0.29–0.966); and self-assessing health status as good/very good (p<0.001; OR = 0.446; CI95% = 0.301–0.66). Undergoing hemodialysis treatment for less than two years increased the chances of CMM (p = 0.03; OR = 1.779; 95%CI = 1.057–2.997) (Table 3).

thumbnail
Table 3. Logistic regression analysis between exposure variables and complex multimorbidity among hemodialysis patients, Brazil, 2019.

https://doi.org/10.1371/journal.pone.0303068.t003

Discussion

This research presents an unprecedented proposal in addressing complex multimorbidity in potentially multimorbid individuals. The findings showed that the prevalence of CMM among individuals undergoing hemodialysis during the study period was 81.1%. This result can be analyzed in relation to the etiological characteristic of chronic kidney disease, as a consequence of other nontransmissible diseases, such as diabetes mellitus and systemic arterial hypertension [16, 18].

When analyzing the variables of the social context according to the proposed analysis model, it was found that the lower general mortality rates of the individuals’ city of residence reduced the chances of CMM.

These data can be analyzed from the perspective of the proposition presented by Krieger [19] when associating the social context of individuals’ lives with the health conditions presented by them. This author proposes a cause-and-effect relationship between social context and health conditions, reinforcing the need to promote public health actions that reduce inequalities [20, 21], since the general mortality rate indirectly reflects the health conditions in which individuals reside. Although there are studies, like this one, that indicate that better social conditions are associated with a lower prevalence of multimorbidity [22], it is necessary to recognize that the present work is pioneering in the investigation of the influence of social context variables on the development of complex multimorbidity in hemodialysis patients.

With regard to individual characteristics, it appears that belonging to the younger age group and having received more than eight years of schooling reduce the chances of CMM by 60% and 47%, respectively. These findings reinforce data that indicate a greater risk of developing nontransmissible diseases among older individuals with lower levels of education, although the results of this study regarding the level of education did not show a significant difference between elementary and secondary and tertiary education levels [2327].

The Technical Series on Safer Primary Care from the World Health Organization [28] highlights the need for monitoring health among older individuals, since the prevalence of multimorbidity in this group is higher than that among younger people. In this sense, the results of this study, unprecedented in the approach to complex multimorbidity in hemodialysis patients, can subsidize the actions of programs and public health policies that aimed at managing the organization of services in the face of the challenge of the growing prevalence of multimorbidity.

In Brazil, the development of health policies focusing on primary health care has made it possible to control diseases such as high blood pressure and diabetes mellitus, which are risk factors for chronic kidney disease [29, 30]. Another aspect to be highlighted is the regionalization of health, which allows a contextualized approach to health education actions developed within the scope of primary health care, in accordance with identified local priorities. This organizational model allows for greater approximation among hemodialysis patients and can be consolidated as an effective strategy for promoting education and health, although the qualification of care for individuals undergoing hemodialysis treatment in primary health care is still being implemented [3133].

The data from this article indicate that positive self-perception of health status is associated with better effective health conditions. The self-assessment of health status has been configured as a important marker of functional disability [34], widely used in epidemiological surveys due to its predictive power on mortality, morbidity and the use of health services. Due to its reliability and validity being equivalent to other more complex assessments of health conditions, self-assessment of health status should be considered an important complement to objective measures [3537]. The results referring to the duration of hemodialysis treatment indicate that individuals undergoing treatments initiated less than two years prior to data collectionare were 77% more likely to experience complex multimorbidity than those have been receiving hemodialysis above ten years. This finding may reflect adaptation to the characteristics of weekly and continuous treatment, and be analyzed from the perspective of the impact that the diagnosis of chronic kidney disease in the end stage has on the individual. Not infrequently, the first reactions to the need for routine adjustment are nonacceptance of the disease and consequent treatment, which may lead to clinical complications associated with CMM [17].

Another aspect to be considered regarding these data (association of shorter hemodialysis treatment time with a greater chance of occurrence of CMM) is the time of diagnosis of chronic kidney disease, since most of these individuals were diagnosed when the disease was already in the terminal phase, and therefore several of their organic systems were already impaired [35].

Although the variable “practice of physical activity” was not maintained in the final logistic regression model, it was associated with the occurrence of CMM in the association analyses and cannot be disregarded as an instrument for health promotion and disease prevention [3640]. Fukushima, Costa and Orlandi [41], in studying the physical activity level of chronic kidney disease patients undergoing hemodialysis, found that most individuals were insufficiently active, which may reflect the treatment routine and concern over fistula maintenance [4144]. However, Da Cunha et al. [45], in researching a similar population, found no association between leisure practices and clinical and treatment characteristics, indicating the need to strengthen public policy actions that allow greater access to physical activity by this population. Although there are no data to support the association between inadequate practice of physical activity and complex multimorbidity, Vancampfort et al. [46], in studying a population of low-income countries, found an association between multimorbidity and low practice of physical activity.

At this point, it is pertinent to highlight the novelty of this study’s proposal, when evaluating CMM in patients with CKD undergoing hemodialysis treatment. The results found indicating a high prevalence of CMM, signal practical implications in the health care of these patients. The clinical management of patients with CKD on hemodialysis with CMM becomes more challenging, especially in coordinating care, choosing appropriate therapies and managing drug interactions. This requires a multidisciplinary, integrated approach to care and an in-depth understanding of each patient’s individual needs [2, 3, 12, 21, 27].

Another aspect to be considered is the increased costs for treating CMM in individuals on hemodialysis. In this sense, the greater financial pressure on health systems as a result of the care demanded, implies the need for a budget planning system focused on the efficiency of resource allocation and management [24]. The management of CMM in patients with CKD undergoing hemodialysis also requires a patient-centered approach and the practice of effective health communication to optimize clinical results, which highlights the need to adopt clinical protocols adapted to individual needs [12, 25, 26].

Additional practical implication that must be highlighted from the results found is related to the fact that to mitigate the high prevalence of complex multimorbidity in hemodialysis patients, it is essential to strengthen public policies with a renewed focus on primary and secondary health prevention, highlighting effective education actions in health [3133].

The high prevalence of complex multimorbidity in patients undergoing hemodialysis identified in this study reveals a scenario that is still little known. The identification of the association of factors such as age group, duration of hemodialysis, self-assessment of health status and general mortality rate with MMC among patients undergoing hemodialysis treatment, enables the adoption of targeted clinical therapeutic approaches in the management of these patients, adapting the treatment protocols and promoting specific preventive interventions. Furthermore, early identification of patients at higher risk can facilitate the implementation of coordinated and multidisciplinary care strategies, aiming to reduce morbidity and mortality in this vulnerable population, thus improving the effectiveness and efficiency of public health services aimed at hemodialysis patients [12, 24, 26, 31].

Finally, the urgent need to identifying CMM data for organizing of the health system is highlighted, since this condition will lead, as a possible consequence, to an increase in the demand for highly complex services. Therefore, propositions about strengthening primary health care [25, 26] seem to be a viable way to reduce the distance between patients with chronic kidney disease and health services, in addition to reducing the costs required to treat the disease and increasing the possibility of investments in health promotion actions.

Regarding the limitations of this study, it is necessary to recognize that data collection on diseases was carried out based on participants’ self-report, which, although it is a valid methodology for the study of CMM, can lead to underreporting due to insufficient knowledge or even to information bias among the individuals involved. It is worth mentioning that, to improve the internal validity of the study, information from medical records was also consulted to evaluate existing diseases, with consequent mitigation of this bias.

Another aspect to be highlighted is the cross-sectional nature of the study, in which the dialogical relationship between the exposure and outcome variables needs to be considered, such as the possibility of reverse causality, especially between the variables general mortality rate of the municipality of residence and self-assessment of health status with MMC. However, to mitigate this effect and control possible confounding factors, control variables on contextual characteristics and individual characteristics were included in the analyses, in addition to the use of robust statistical approaches. The appropriate statistical treatment of these variables allowed a more precise and reliable analysis of the factors associated with MMC in patients undergoing hemodialysis treatment, as described in the Materials and Methods section.

Another limitation that deserves to be highlighted is the fact that in this study it was not possible to identify the cause of nephropathy. Therefore, patients who reported diabetes and hypertension may have presented these conditions as a cause of nephropathy and not as a consequence of kidney disease, as in the theoretical model proposed by this study.

However, the absence of a single standard for the scientific assessment of multimorbidity, combined with the lack of research on the topic involving patients with chronic kidney disease undergoing hemodialysis, limited the comparison of results. We conclude that the prevalence of complex multimorbidity is high in patients with chronic kidney disease undergoing hemodialysis treatment. This indicates that, in addition to hemodialysis treatment, these individuals demand other health-care services of medium and high complexity with assistance from multidisciplinary teams.

The factors that reduced the chances of the occurrence of CMM among chronic kidney disease patients on hemodialysis were: a low mortality rate in the municipality of residence; aged group between 18 and 29 years; positive self-rated health; and eight years or more of schooling, thus reinforcing the role of contextual and individual characteristics.

On the other hand, treatment for less than two years was a factor that increased the chances of CMM, which indicates the need for monitoring health, especially for individuals who have a clinical condition at risk of chronic kidney disease. Thus, public health policies that promote effective health education actions, follow-up of individuals under continuous treatment, such as hemodialysis, within the health-care network, and monitoring of multimorbid individuals are presented as viable public policy actions in the approach to complex multimorbidity in hemodialysis patients.

Supporting information

References

  1. 1. Ford JC, Ford JA. Multimorbidity: will it stand the test of time? Age Ageing. 2018;47(1): 6–8. pmid:29036276
  2. 2. World Health Organization. Primary health care: now more than ever. Geneva: World Health Organization. 2008 [Cited 2022 Dezember 17]. Available from: https://www.who.int/whr/2008/en/
  3. 3. Starfield B. Challenges to primary care from co- and multi-morbidity. Prim Health Care Res Dev. 2011;12(01): 1–2. pmid:21426609
  4. 4. Xu X, Mishra GD, Jones M. Evidence on multimorbidity from definition to intervention: an overview of systematic reviews. Ageing Res Rev. 2017;37: 53–68. pmid:28511964
  5. 5. Le Reste JY, Nabbe P, Manceau B, Lygidakis C, Doerr C, Lingner H, et al. The European General Practice Research Network presents a comprehensive definition of multimorbidity in family medicine and long term care, following a systematic review of relevant literature. J Am Med Dir Assoc. 2013;14(5): 319–325. pmid:23411065
  6. 6. Diederichs C, Berger K, Bartels DB. The measurement of multiple chronic diseases: a systematic review on existing multimorbidity indices. J Gerontol A Biol Sci Med Sci. 2011;66A(3): 301–311. pmid:21112963
  7. 7. NICE Guideline. Multimorbidity: clinical assessment and management. UK. 2016 [Cited 2022 Dezember 17]. Available from: https://www.nice.org.uk/guidance/ng56/resources/multimorbidity-clinical-assessment-and-management-pdf-1837516654789
  8. 8. da Silva AF, Moreira EAM, Barni GC, Panza VSP, Furkim AM, Moreno YMF. Relationships between high comorbidity index and nutritional parameters in patients with oropharyngeal dysphagia. Clin Nutr ESPEN. 2020;38: 218–222. pmid:32690161
  9. 9. Rzewuska M, de Azevedo-Marques JM, Coxon D, Zanetti ML, Zanetti ACG, Franco LJ, et al. Epidemiology of multimorbidity within the Brazilian adult general population: evidence from the 2013 National Health Survey (PNS 2013). PLoS ONE. 2017;12(2): e0171813. pmid:28182778
  10. 10. Harrison C, Henderson J, Miller G, Britt H. The prevalence of complex multimorbidity in Australia. Aust N Z J Public Health. 2016;40(3): 239–244. pmid:27027989
  11. 11. Harrison C, Britt H, Miller G, Henderson J. Examining different measures of multimorbidity, using a large prospective cross-sectional study in Australian general practice. BMJ Open. 2014;4(7): e004694. pmid:25015470
  12. 12. Política Nacional de Atenção Básica. Brasília: Ministério da Saúde. 2007 [Cited 2022 Dezember 17]. Available from: https://bvsms.saude.gov.br/bvs/publicacoes/politica_nacional_atencao_basica_4ed.pdf
  13. 13. Instituto Brasileiro de Geografia e Estatística (IBGE). Censo demográfico. Brasília: IBGE. 2010. [Cited 2022 Dezember 17]. Available from: https://censo2010.ibge.gov.br/
  14. 14. Instituto Brasileiro de Geografia e Estatística (IBGE). Departamento de Informática do SUS ‐ DATASUS. Informações de Saúde, Epidemiológicas e Morbidade: banco de dados. [Cited 2022 Dezember 17]. Available from: <http://www2.datasus.gov.br/DATASUS/index.php?area=0203
  15. 15. Reisen A, Leite FMC, Santos Neto ET dos. Associação entre capital social e bullying em adolescentes de 15 a 19 anos: relações entre o ambiente escolar e social. Ciênc. Saúde Coletiva. 2021;26(suppl 3): 4919–4932. doi: https://doi.org/10.1590/1413-812320212611.3.21522019.
  16. 16. Grootaert C, Bastelaer TV. Understanding and measuring social capital. A synthesis of findings and recommendations from the social capital initiative. Washington DC: The World Bank. 2001 [Cited 2022 Dezember 17]. Available from: https://pdf.usaid.gov/pdf_docs/PNACP765.pdf
  17. 17. de Oliveira Soares AC, Cattafesta M, Paixão MPCP, Dos Santos Neto ET, Salaroli LB. Determinants of access to hemodialysis services in a metropolitan region of Brazil. BMC Public Health. 2022;22(1):1868. pmid:36207731
  18. 18. Collins AJ, Foley RN, Gilbertson DT, Chen SC. United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease. Kidney Int Suppl (2011). 2015;5(1): 2–7. pmid:26097778
  19. 19. Krieger N. Theories for social epidemiology in the 21st century: an ecosocial perspective. Int J Epidemiology. 2001. 30(4): 668–677. pmid:11511581
  20. 20. Nunes CFO, Ramos Júnior AN. Judicialização do direito à saúde na região Nordeste, Brasil: dimensões e desafios. Cad Saúde Colet. 2016;24(2): 192–199.
  21. 21. Dahlgren G, Whitehead M. Policies and strategies to promote social equity in health. Background document to WHO–strategy paper for Europe. Stockholm: Institute for Future Studies. 1991 [Cited 2022 Dezember 17]. Available from: https://core.ac.uk/download/pdf/6472456.pdf
  22. 22. Skou ST, Mair FS, Fortin M, Guthrie B, Nunes BP, Miranda JJ, et al. Multimorbidity. Nat Rev Dis Primers. 2022;8(1):48. pmid:35835758
  23. 23. Fernandes FT, Silva DRM e, Campos F, Santana VS, Cuani L, Curado MP, et al. Recovering records on cancer of the larynx from anonymous health information databases. Rev Bras Epidemiol. 2021;24: e210011. pmid:33825773
  24. 24. Neves RG, Duro SMS, Nunes BP, Facchini LA, Tomasi E. Atenção à saúde de pessoas com diabetes e hipertensão no Brasil: estudo transversal do Programa de Melhoria do Acesso e da Qualidade da Atenção Básica, 2014. Epidemiol Serv Saúde. 2021;30(3): e2020419. pmid:34287554
  25. 25. Moin JS, Glazier RH, Kuluski K, Kiss A, Upshur REG. Examine the association between key determinants identified by the chronic disease indicator framework and multimorbidity by rural and urban settings. J Comorb. 2021;11: 263355652110281. pmid:34262879
  26. 26. Melo LA de, Lima KC de. Prevalência e fatores associados a multimorbidades em idosos brasileiros. Ciênc Saúde Coletiva. 2020;25(10): 3869–3877. pmid:32997019
  27. 27. Malta DC, Silva MMA da. As doenças e agravos não transmissíveis, o desafio contemporâneo na Saúde Pública. Ciênc saúde coletiva. 2018;23(5): 1350–1350. pmid:29768591
  28. 28. World Health Organization. Technical Series on Safer Primary Care: Multimorbidity. 2016 [Cited 2026 July 5]. Available from: https://www.who.int/teams/integrated-health-services/patient-safety/research/safer-primary-care
  29. 29. Petarli GB, Cattafesta M, Sant’Anna MM, Bezerra OM de PA, Zandonade E, Salaroli LB. Multimorbidity and complex multimorbidity in Brazilian rural workers. PLoS ONE. 2019;14(11): e0225416. pmid:31743369
  30. 30. Nunes BP, Chiavegatto Filho ADP, Pati S, Cruz Teixeira DS, Flores TR, Camargo-Figuera FA, et al. Contextual and individual inequalities of multimorbidity in Brazilian adults: a cross-sectional national-based study. BMJ Open. 2017;7(6): e015885. pmid:28601836
  31. 31. Ministério da Saúde. Política Nacional de Atenção ao Portador de Doença Renal, a ser implantada em todas as unidades federadas, respeitadas as competências das três esferas de gestão. Brasília. 2004 [Cited 2022 Dezember 17]. Available from: https://bvsms.saude.gov.br/bvs/saudelegis/gm/2014/prt0389_13_03_2014_rep.html
  32. 32. Mendes, E. V. O cuidado das condições crônicas na atenção primária à saúde: o imperativo da consolidação da estratégia da saúde da família. Brasília: OPAS. 2012 [Cited 2022 Dezember 17]. Available from: https://bvsms.saude.gov.br/bvs/publicacoes/cuidado_condicoes_atencao_primaria_saude.pdf
  33. 33. Mendes EV. As redes de atenção à saúde no SUS. Ciênc. Saúde Coletiva. 2010;15(5): 2297–2305. pmid:20802863
  34. 34. DeSalvo KB, Muntner P. Discordance Between Physician and Patient Self-Rated Health and All-Cause Mortality. Ochsner J. 2011;11(3): 232–240. Available from: https://pubmed.ncbi.nlm.nih.gov/21960756/ pmid:21960756
  35. 35. Garcia LP, Höfelmann DA, Facchini LA. Self-rated health and working conditions among workers from primary health care centers in Brazil. Cad Saúde Pública 2010; 26:971–80. pmid:20563397
  36. 36. Quesnel-Vallée A. Self-rated health: caught in the crossfire of the quest for “true” health? Int J Epidemiol 2007; 36:1161–4. pmid:18056123
  37. 37. Mood C. Life-style and self-rated global health in Sweden: a prospective analysis spanning three decades Prev Med 2013; 57:802–6
  38. 38. Theme Filha MM, Szwarcwald CL, Souza Junior PRB de. Medidas de morbidade referida e inter-relações com dimensões de saúde. Rev Saúde Pública. 2008;42(1): 73–81. pmid:18200343
  39. 39. Lerma C, Lima-Zapata LI, Amaya-Aguilar JA, Leonardo-Cruz I, Lazo-Sánchez M, Bermúdez LA, et al. Gender-specific differences in self-care, treatment-related symptoms, and quality of life in hemodialysis patients. Int J Environ Res Public Health. 2021;18(24): 13022. pmid:34948632
  40. 40. Sullivan MK, Jani BD, McConnachie A, Hanlon P, McLoone P, Nicholl BI, et al. Hospitalisation events in people with chronic kidney disease as a component of multimorbidity: parallel cohort studies in research and routine care settings. BMC Med. 2021;19(1): 278. pmid:34794437
  41. 41. Fukushima RLM, Costa JLR, Orlandi F de S. Atividade física e a qualidade de vida de pacientes com doença renal crônica em hemodiálise. Fisioter Pesqui. 2018;25(3): 338–344.
  42. 42. Malhotra R, Kumar U, Virgen P, Magallon B, Garimella PS, Chopra T, et al. Physical activity in hemodialysis patients on nondialysis and dialysis days: prospective observational study. Hemodial Int. 2021;25(2): 240–248. pmid:33650200
  43. 43. Wu YH, Hsu YJ, Tzeng WC. Physical activity and health-related quality of life of patients on hemodialysis with comorbidities: A cross-sectional study. Int J Environ Res Public Health. 2022;19(2): 811. pmid:35055633
  44. 44. Moraes ADS, Souza AM de, Sena TCDCB de, Falcão LFM, Corrêa VAC. Changesin occupational perf ormance of individuals with chronic kidney disease undergoingperitoneal dialysis. REFACS (online). 2018;6 (Supl. 2): 591–599. acs.v6i0.3129.
  45. 45. Cardoso da Cunha A, Theodoro dos Santos Neto E, Cattafesta M, Bresciani Salaroli L. Factors associated with the leisure pratice of individuals on hemodialysis. J Hum Growth Dev. 2022;32(2): 232–241.
  46. 46. Vancampfort D, Koyanagi A, Ward PB, Rosenbaum S, Schuch FB, Mugisha J, et al. Chronic physical conditions, multimorbidity and physical activity across 46 low- and middle-income countries. Int J Behav Nutr Phys Act. 2017;14(1):6. pmid:28100238